Bird & Bird advises Northern Green Canada on operations in the cannabis market
Written By
Bird & Bird LLP advises Northern Green Canada Inc. (NGC) on its global expansion and the establishment of Northern Green Global GmbH, based in Unterschleissheim, Germany, which provides cannabinoid medicines to global markets. Northern Green Canada Inc. (NGC) is the first privately owned cannabis producer in Canada.
Northern Green Canada Inc. is a research and development-oriented EU-GMP-certified manufacturer of high-quality medical cannabis, focused on providing pharmaceutical cannabis products and the development of cannabinoid formulations to treat chronic diseases, and improve patients’ quality of life. The company is currently expanding its extraction capacities to produce oils and is working with renowned partners on treatment-based cannabis drugs.
The following Bird & Bird lawyers advised NGC: Partner Dr. Kai Kerger (lead), associates Johanna Schindler, and Dr. Ann-Kristin Asmuß (all corporate, Frankfurt), partner Dr. Niels Lutzhöft, associates Dr. Simon Hembt, and Dr. Christoph Hendel (all commercial/regulatory, Frankfurt), partner Dr. Barbara Geck and associate Carina Seum (both employment, Frankfurt).
Background
Bird & Bird is a pioneer in advising clients in the medical cannabis field with its long-standing and cross-legal sector expertise. Our international cannabis group advises market leaders in this fast-growing industry.